Victoria Bray
About
Victoria Bray is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research.
According to data from OpenAlex, Victoria Bray has authored 49 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Victoria Bray's work include Lung Cancer Treatments and Mutations (19 papers), Cancer Genomics and Diagnostics (9 papers) and Head and Neck Cancer Studies (8 papers). Victoria Bray is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Cancer Genomics and Diagnostics (9 papers) and Head and Neck Cancer Studies (8 papers). Victoria Bray collaborates with scholars based in Australia, United States and United Kingdom. Victoria Bray's co-authors include Janette L. Vardy, Haryana M. Dhillon, Melanie L. Bell, Therese M. Becker, Wei Chua, Mallorie H. Fiero, Chee Khoon Lee, James Chih‐Hsin Yang, Sarah J. Lord and Val Gebski and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.
In The Last Decade
Victoria Bray
46 papers receiving 892 citations
Peers
Victoria Bray
Jonathan D. Clapp United States
Babu Zachariah United States
Arturo Navarro-Martín Spain
L. D. Case United States
Gavin Taylor‐Stokes United Kingdom
John Coombs United States
Miranda J.M. Dirx Netherlands
Ramachandran Venkitaraman United Kingdom
Steven A. Kuross United States
Albert S. DeNittis United States
Citations per year, relative to Victoria Bray Victoria Bray (= 1×)
peers
Jonathan D. Clapp
Countries citing papers authored by Victoria Bray
Since
Specialization
Citations
This map shows the geographic impact of Victoria Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Bray more than expected).
Fields of papers citing papers by Victoria Bray
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Victoria Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Bray. The network helps show where Victoria Bray may publish in the future.
Co-authorship network of co-authors of Victoria Bray
This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Bray. A scholar is included among the top collaborators of Victoria Bray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Bray. Victoria Bray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bray, Victoria, et al.. (2024). Variations in Patterns of Prescribing Durvalumab in Stage III Lung Cancer: A Survey of Australian Medical Oncologists. Oncology. 102(8). 732–736.
2.
Bray, Victoria, Po Yee Yip, Anthony Linton, et al.. (2024). Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer. Journal of Geriatric Oncology. 15(2). 101705–101705.
3.
Pal, Abhijit, Adnan Nagrial, Jenny Lee, et al.. (2023). Influence of EGFR mutation status and PD‐L1 expression in stage III unresectable non‐small cell lung cancer treated with chemoradiation and consolidation durvalumab. Asia-Pacific Journal of Clinical Oncology. 20(1). 16–24.
4.
Vinod, Shalini, et al.. (2023). Implementation and evaluation of a geriatric-oncology model of care for older adults with lung cancer. Journal of Geriatric Oncology. 14(8). 101578–101578.
5.
Sousa, Mariana S., Peter Martin, Miriam J. Johnson, et al.. (2023). Phase II, double blind, placebo controlled, multi-site study to evaluate the safety, feasibility and desirability of conducting a phase III study of anamorelin for anorexia in people with small cell lung cancer: A study protocol (LUANA trial). PLoS ONE. 18(5). e0285850–e0285850.
6.
Smith, Kylie, et al.. (2022). Adapting an integrated care pathway for implementing electronic patient reported outcomes assessment in routine oncology care: Lessons learned from a case study. Journal of Evaluation in Clinical Practice. 28(6). 1072–1083.
7.
Roberts, Tara L., Wei Chua, Therese M. Becker, et al.. (2021). Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinib. Translational Lung Cancer Research. 10(4). 1623–1634.
8.
Lin, Peter, Myo Min, Kaitao Lai, et al.. (2021). Mid-treatment Fluorodeoxyglucose Positron Emission Tomography in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy: Nodal Metabolic Response Rate can Predict Treatment Outcomes. Clinical Oncology. 33(12). e586–e598.
9.
Girgis, Afaf, et al.. (2021). Treatment burden experienced by patients with lung cancer. PLoS ONE. 16(1). e0245492–e0245492.
10.
Wetter, Julie, Petra Kraus, Shawgi Sukumaran, et al.. (2020). 1846P Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer. Annals of Oncology. 31. S1058–S1059.
11.
Bell, Melanie L., Lysbeth Floden, Stacie Hudgens, et al.. (2019). <p>Analytical approaches and estimands to take account of missing patient-reported data in longitudinal studies</p>. Patient Related Outcome Measures. Volume 10. 129–140.
12.
Ding, Pei Ni, Therese M. Becker, Victoria Bray, et al.. (2019). The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study. Lung Cancer. 134. 187–193.
13.
Bell, Melanie L., Nicholas J. Horton, Haryana M. Dhillon, Victoria Bray, & Janette L. Vardy. (2018). Using generalized estimating equations and extensions in randomized trials with missing longitudinal patient reported outcome data. Psycho-Oncology. 27(9). 2125–2131.
14.
Bray, Victoria, Haryana M. Dhillon, & Janette L. Vardy. (2017). Cancer-related cognitive impairment in adult cancer survivors: A review of the literature. Cancer Forum. 41(1). 46.
15.
Bell, Melanie L., Mallorie H. Fiero, Haryana M. Dhillon, Victoria Bray, & Janette L. Vardy. (2017). Statistical controversies in cancer research: using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes. Annals of Oncology. 28(8). 1730–1733.
16.
Lin, Peter, Myo Min, Mark Lee, et al.. (2016). Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers. European Journal of Nuclear Medicine and Molecular Imaging. 44(5). 801–811.
17.
Lord, Sarah J., Val Gebski, Matthew Links, et al.. (2016). Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(4). 633–643.
18.
Min, Myo, Peter Lin, Ivan Ho Shon, et al.. (2016). Prognostic Value of 2-[18F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria. Clinical Oncology. 28(6). 393–401.
19.
Kok, Peey‐Sei, et al.. (2015). 369O Timing of palliative care referral and its impact on receiving aggressive end of life care in patients with metastatic non-small cell lung cancer (NSCLC) in Southwest Sydney. Annals of Oncology. 26. ix111–ix111.
20.
Min, Myo, Peter Lin, Mark Lee, et al.. (2015). Prognostic role of metabolic parameters of 18F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 42(13). 1984–1994.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jonathan D. Clapp Breakdown of academic impact, for papers by Babu Zachariah Breakdown of academic impact, for papers by Arturo Navarro-Martín Breakdown of academic impact, for papers by L. D. Case Breakdown of academic impact, for papers by Gavin Taylor‐Stokes Breakdown of academic impact, for papers by John Coombs Breakdown of academic impact, for papers by Miranda J.M. Dirx Breakdown of academic impact, for papers by Ramachandran Venkitaraman Breakdown of academic impact, for papers by Steven A. Kuross Breakdown of academic impact, for papers by Albert S. DeNittis